IIP is fortunate to be able to draw on the expertise of an active advisory board that includes leading healthcare scientists and investors through to financial service experts, all of whom care deeply about making an impact.

Prof. Molly Stevens

United Kingdom

Molly Stevens is Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering at Imperial College London.

In 2010, Molly was recognized by The Times as one of the top ten scientists under the age of 40. She has also been recognized by the TR100, a compilation of the top innovators under the age of 35, who are transforming technology and the world with their work. Molly is a recipient of the Polymer International-IUPAC award for creativity in polymer science, the Rosenhain medal and the Norman Heatley Prize for Interdisciplinary Research from the Royal Society of Chemistry, the Jean Leray Award from the European Society for Biomaterials, the Conference

Science Medal from the Royal Pharmaceutical Society and the Philip Leverhulme Prize for Engineering, the Ronald Belcher Memorial Lecture Award from the Royal Society of Chemistry, the Janssen Prize and the UpJohn Prize for academic excellence and research.

Molly holds a First Class Honors degree in Pharmaceutical Sciences from Bath University and a PhD in biophysical investigations of specific bimolecular interactions and single biomolecule mechanics from the Laboratory of Biophysics and Surface Analysis at the University of Nottingham and has had Postdoctoral training in the laboratory of Professor Robert Langer in the Chemical Engineering Department at the Massachusetts Institute of Technology (MIT).



David Kyle

United States of America

In 2013 David founded Impact Business Leaders, a Washington, DC-based company which is focused on matching experienced business professionals looking for career change in to full time roles with social enterprises around the world. IBL has training centers at the University of Virginia’s Darden Business School; the Said Business School at Oxford University, and new centers in Nairobi and Hyderabad, India. Prior to starting IBL David was at the Calvert Foundation in Bethesda, Maryland as COO since 2011.

Prior to joining Calvert Foundation David lived in Hyderabad, India for three years where he was the Founder and CEO of the Indian School Finance Company, a for-profit finance company that provides medium term debt capital to private schools serving very low-income families. The still thriving ISFC was one of a string of start-ups David has led over the past 20 years starting with building a Citibank subsidiary into a full service commercial bank in Lisbon, Portugal from 1990-96; building Citibank’s first global intranet system in the late-1990s which he did from London; and, establishing a new country organization for Save the Children in Brazil upon leaving Citibank in 2001.

As COO and Chief Investment Officer of Acumen Fund, he built local operations in East Africa, India, Pakistan and New York from 2003-07. Prior to beginning his career in social enterprise in 2001 David spent 20 years in the corporate and investment bank of Citibank working successively in Brazil, Hong Kong, Saudi Arabia, Portugal and the UK.

Since 2006 David has pursued parallel teaching activities in several graduate programs in the US and abroad starting with Columbia SIPA (2006-7); Hyderabad-based Indian School of Business (2008-10); Emory University’s Goizueta MBA program (since 2011); and, at American University (since 2013).

David went to Trinity College in Hartford, Connecticut and has an MA in International Relations from the Johns Hopkins University.



Andrea Tobias, PhD

United States of America

Andrea Tobias, PhD is Managing Director of the Aquila Consulting Group, LLC, San Francisco where she focuses on developing new models to fund innovation. She is currently a San Francisco-based Venture Partner/Advisor for Brandon Capital Partners (Australia) and a strategic advisor for the Global Health shares initiative at UC Davis. From 2007-09 she spent two years as the Portfolio Advisor to Fast Forward, the venture philanthropy arm of the US National MS Society, where she created and launched three new funds and raised $19m to fund them.

Andrea previously was a partner at CMEA Ventures (San Francisco) from 2001 to 2006. At CMEA, she was part of the life science team that managed the $160m Life Sciences fund V, and helped raise and invest the $300m Life Sciences/IT Fund VI. Prior to CMEA, Andrea spent four years as an Assistant Director in venture capital for Apax Partners & Cie Ventures (Paris) and Abingworth Management (London), where she focused on the biotechnology, healthcare and health net sectors.

Andrea has also held management positions for 8 years in the US biotech industry and was Director of Strategic Development for Chiron Corporation and Manager of New Research Identification for Genentech. In addition, she served as the R&D liaison for foreign subsidiaries in Canada, Japan, and Switzerland.

Andrea has a degree in Physiology/Anatomy from the University of California, Berkeley and a PhD in Endocrinology from the University of California-San Francisco School of Medicine.


R. Guru Moorthy


Guru founded Napier Healthcare (formerly Karishma Software Ltd.) in 1996 and remained an Executive Director until March 2010. Established to provide 'excellence in healthcare management’, Napier now manages more than 50,000 beds in 80 healthcare institutions in 7 countries, including China, South Africa, Dubai, Kenya , and Malaysia. Napier won the IBM Top Star Award for Healthcare in 2008, and the Frost & Sullivan Indian HIS (Hospital Information System) Company of the Year in 2009 and 2010.

Guru is currently a Director of both India Insure Risk Management Services Pvt., a Corporate Insurance Agent that he helped build from 9 members to over 100 employees across 8 branches over 10 years, and MEdRC EduTech, a pioneer in digitally enabled healthcare education. Guru acts as Advisor to Jupiter Hospital, a 200-bed multispecialty tertiary care centre in West Mumbai, and Pushpagiri Eye Institute, a non-profit organization dedicated to preventing treatable eye disease at an affordable price.

Guru has a BSc and an MBA form Osmania University, Hyderabad. He is also a seed investor into IIP’s asset management company.


Ida Beerhalter


Ida Beerhalter is Co-Head of IOME, a private investment partnership of women principals from the Gulf with its head office in Riyadh, Kingdom of Saudi Arabia.

Prior to her current role she served as Investment Partner at Bellwald Partner GmbH, a German multi-family office; as Director Corporate Affairs at Cardionovum GmbH focusing on the commercialization and out-licensing of its drug-eluting balloon technologies, novel DES Generations and biodegradable vascular scaffolds; as Head of Business Development at NonWoTecc Medical GmbH and as Vice President of Business Development at mNEMOSCIENCE GmbH. Ida also spent 5 years at the KRAUTH group in various senior level positions including Director of Business Development, Sales Manager and, Training and Education Manager.

Ida is also a member of the Board of Trustees of Astia, a unique not-for-profit organization build on a community of over 3000 experts dedicated to propel women’s full participation as entrepreneurs and leaders in high-growth businesses, an Advisor to Yunus Social Business GmbH, Germany which is dedicated to setting up and investing in non-dividend companies created to solve social or environmental problems.


SME Financing

Nick Robins

Nick Robins is the Co-Director, Inquiry into the Design of a Sustainable Financial System at UNEP. Previously, he was the Head of the Climate Change Centre of Excellence at HSBC in London. Nick has co-authored research on low-carbon opportunities in bond and equity markets, as well as long-term carbon and water risks. In the Thomson Extel awards for European investment research, Nick was ranked as #1 analyst for integrated climate change in 2009, 2011, 2012 and 2013. Nick is a member of GE’s Corporate Citizenship Panel, as well as the Guardian newspaper’s Sustainable Business panel.

Tone Wille


Tone Wille is Executive Vice President/CFO/IT of Posten Norge, a Public Company with annual sales of NOK 23 billion and approximately 22000 employees. She has more than 20 years management and private equity experience across developed and emerging markets. Prior to taking on her role at Posten, Tone was Deputy Managing Director of Norfund, (Norwegian Investment Fund for Developing Countries) an specialist emerging markets investment firm with over NOK 5.8 billion in assets under management invested in over 85 companies and funds.

In her role there, Tone was responsible for strategic investments into private equity fund management companies. She was also a member of Norfund’s investment committee; a Board Director of SN Power, a specialised renewable energy investment firm with 1.75 billion of assets under management; and a Board Director of Aureos Capital Ltd, a specialist private equity firm that builds sustainable small and medium-sized businesses in emerging markets. Aureos first and second generation funds, with over US$1.3 billion of Capital Commitments, have invested in over 135 investments worldwide. Tone has also been CFO of Kvaerner Energy, a specialised international engineering procurement and construction company belonging to the Kvaerner Group which has 13 295 billion in annual sales and Senior VP and CFO at GE Energy Norway.